A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies
Ossium Health, Inc.
Ossium Health, Inc.
Terns, Inc.
M.D. Anderson Cancer Center
Children's Oncology Group
Novartis
Stanford University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Astex Pharmaceuticals, Inc.
Sun Pharma Advanced Research Company Limited
Columbia University
Roswell Park Cancer Institute
M.D. Anderson Cancer Center
Indiana University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Charite University, Berlin, Germany
Fate Therapeutics
Takeda
Kartos Therapeutics, Inc.
Teva Branded Pharmaceutical Products R&D, Inc.
Novartis
University of Michigan Rogel Cancer Center
National Cancer Institute (NCI)
Novartis
Novartis
Novartis
University Health Network, Toronto
M.D. Anderson Cancer Center
Bio-Path Holdings, Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Fusion Pharma LLC
Mirror Biologics, Inc.
Hospital de Clinicas de Porto Alegre
Cell Medica Ltd
Il-Yang Pharm. Co., Ltd.
National Institutes of Health Clinical Center (CC)
Stanford University
National Cancer Institute (NCI)
Prism Pharma Co., Ltd.
Fred Hutchinson Cancer Center
Traws Pharma, Inc.
Washington University School of Medicine
Singapore General Hospital
Sheba Medical Center
Cellerant Therapeutics
Baylor College of Medicine
Polyphor Ltd.
University of Leipzig
University of Michigan Rogel Cancer Center